Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001649553-26-000036·CVI Investments, Inc.
Schedule 13G ownership disclosure
REVIVA PHARMACEUTCLS HLDGS I
Common Stock, $0.0001 par value per share · CUSIP: 76152G209
Event date: 2026-03-18
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- CVI Investments, Inc.
Shares: 666,667 · Class: 5.2%
- Heights Capital Management, Inc.
Shares: 666,667 · Class: 5.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001649553-26-000036
- Form type
- SCHEDULE 13G
- Filer
- CVI Investments, Inc.
- CIK
- CIK 1649553
- Filed
- Mar 25, 2026
- Reporting period
- Mar 18, 2026
- Description
- Schedule 13G beneficial ownership